Drugs by Condition

Atrial Fibrillation Medications

Definition of Atrial Fibrillation: A condition where there is disorganised electrical conduction in the atria, resulting in ineffective pumping of blood into the ventricle.

Acronym: AF

Drugs associated with Atrial Fibrillation

The following drugs and medications are in some way related to, or used in the treatment of Atrial Fibrillation. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

See sub-conditions

Drug Name ( View by: Brand \| Generic )	Reviews	Ratings
Cardizem (Pro, More...) generic name: diltiazem class: calcium channel blocking agents, group IV antiarrhythmics	1 review(s)	Rate It!	10
Cardizem CD (Pro, More...) generic name: diltiazem class: calcium channel blocking agents, group IV antiarrhythmics	1 review(s)	Rate It!	7.0
Cardizem LA (Pro, More...) generic name: diltiazem class: calcium channel blocking agents, group IV antiarrhythmics	1 review(s)	Rate It!	8.0
Cartia XT (Pro, More...) generic name: diltiazem class: calcium channel blocking agents, group IV antiarrhythmics	3 review(s)	Rate It!	10
Catapres (More...) generic name: clonidine class: antiadrenergic agents, centrally acting	0 review(s)	Not rated - Be the first
Coreg (Pro, More...) generic name: carvedilol class: beta-adrenergic blocking agents, non-cardioselective beta blockers	0 review(s)	Not rated - Be the first
Coreg CR (Pro, More...) generic name: carvedilol class: beta-adrenergic blocking agents, non-cardioselective beta blockers	1 review(s)	Rate It!	6.0
Digitek (More...) generic name: digoxin class: group V antiarrhythmics, inotropic agents	0 review(s)	Not rated - Be the first
Dilacor XR (Pro, More...) generic name: diltiazem class: calcium channel blocking agents, group IV antiarrhythmics	0 review(s)	Not rated - Be the first
Diltia XT (Pro, More...) generic name: diltiazem class: calcium channel blocking agents, group IV antiarrhythmics	0 review(s)	Not rated - Be the first
Diltzac (More...) generic name: diltiazem class: calcium channel blocking agents, group IV antiarrhythmics	0 review(s)	Not rated - Be the first
Lanoxin (Pro, More...) generic name: digoxin class: group V antiarrhythmics, inotropic agents	0 review(s)	Rate It!	9.0
Lopressor (Pro, More...) generic name: metoprolol class: beta-adrenergic blocking agents, cardioselective beta blockers	0 review(s)	Not rated - Be the first
Metoprolol Succinate ER (More...) generic name: metoprolol class: beta-adrenergic blocking agents, cardioselective beta blockers	1 review(s)	Rate It!	9.0
Multaq (Pro, More...) generic name: dronedarone class: antiarrhythmic agents, group III antiarrhythmics	0 review(s)	Rate It!	1.0
Rythmol (Pro, More...) generic name: propafenone class: antiarrhythmic agents, group I antiarrhythmics	1 review(s)	Rate It!	9.0
Rythmol SR (More...) generic name: propafenone class: antiarrhythmic agents, group I antiarrhythmics	8 review(s)	Rate It!	8.8
Tambocor (More...) generic name: flecainide class: antiarrhythmic agents, group I antiarrhythmics	3 review(s)	Rate It!	9.7
Tiazac (More...) generic name: diltiazem class: calcium channel blocking agents, group IV antiarrhythmics	0 review(s)	Not rated - Be the first
Toprol-XL (More...) generic name: metoprolol class: beta-adrenergic blocking agents, cardioselective beta blockers	2 review(s)	Rate It!	7.7
20 most popular shown. Show all 26...

Atrial Fibrillation Medications in the Pipeline

Kynapid (vernakalant)

August 12, 2009 - Additional Clinical Trial to be Conducted for Kynapid Under FDA Special Protocol Agreement
October 9, 2008 - Cardiome Provides Kynapid Regulatory Update
August 11, 2008 - Cardiome And Astellas Announce Receipt Of FDA Approvable Letter For Kynapid
January 22, 2008 - Cardiome And Astellas Announce Kynapid Regulatory Update
December 12, 2007 - FDA Advisory Committee Recommends Approval of Kynapid for Acute Atrial Fibrillation
August 30, 2007 - Cardiome And Astellas Announce Regulatory Extension
February 19, 2007 - Cardiome And Astellas Announce Acceptance Of NDA For Review
December 18, 2006 - Cardiome and Astellas Pharma US, Inc. Announce Re-Submission of NDA for Vernakalant (IV)
May 31, 2006 - Cardiome Announces Refusal to File Decision By the FDA
March 31, 2006 - New Drug Application Submitted For RSD1235

Pulzium (tedisamil)

December 13, 2007 - Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
September 26, 2007 - Solvay Pharmaceuticals, Inc. Announces FDA Extension of Tedisamil PDUFA Date
April 25, 2007 - Solvay Pharmaceuticals Files Tedisamil, a New Cardiometabolic Product for the Treatment of Atrial Fibrillation and Atrial Flutter

Latest Atrial Fibrillation Blog Post

Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing
- Pharmacokinetic Analysis of Atrial Fibrillation Study May Explain Bleeding Rate Difference between Once-Daily and Twice-Daily Dosing Regimens with Same Total Exposure of Factor Xa Inhibitor - BOSTON and EDISON, N.J., July 15 /PRNewswire/ -- A sub-analysis of...

View all Atrial Fibrillation blog posts.